Zonampanel

CAS No. 210245-80-0

Zonampanel( YM 872 )

Catalog No. M13341 CAS No. 210245-80-0

Zonampanel (YM 872) is a selective, potent and highly water-soluble, competitive AMPA receptor (AMPAR) antagonist with Ki of 96 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 374 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Zonampanel
  • Note
    Research use only, not for human use.
  • Brief Description
    Zonampanel (YM 872) is a selective, potent and highly water-soluble, competitive AMPA receptor (AMPAR) antagonist with Ki of 96 nM.
  • Description
    Zonampanel (YM 872) is a selective, potent and highly water-soluble, competitive AMPA receptor (AMPAR) antagonist with Ki of 96 nM; shows very low affinity for other ionotropic glutamate receptors; competitively antagonizes kainate-induced currents in Xenopus laevis oocytes with a pA2 value of 6.97; exhibits great potential for treatment of neurodegenerative disorders such as stroke.Stroke Discontinued.
  • In Vitro
    Zonampanel inhibits the human MRP4-mediated transport of [3H]oestradiol 17-D-glucuronide in a concentration-dependent manner. In contrast, Zonampanel (up to 1000 mM) does not inhibit the human MRP2- or BCRP-mediated transport of [3H]oestradiol 17-D-glucuronide or [3H]methotrexate. Zonampanel inhibits the uptake of typical substrates by Oat1, Oat2, and Oat3 with inhibition constant (Ki) values of 7.02 to 10.4 μM. A time- and saturable concentration-dependent increase in [14C]Zonampanel uptake is observed in these cells [Km values: 13.4 to 53.6 μM].
  • In Vivo
    In in vivo experiments, probenecid and cimetidine decrease intrinsic clearance for both the renal secretion and biliary excretion of Zonampanel.
  • Synonyms
    YM 872
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    iGluR
  • Recptor
    iGluR
  • Research Area
    Neurological Disease
  • Indication
    Stroke

Chemical Information

  • CAS Number
    210245-80-0
  • Formula Weight
    331.241
  • Molecular Formula
    C13H9N5O6
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (150.95 mM)
  • SMILES
    O=C(O)CN1C(C(NC2=C1C=C(N3C=CN=C3)C([N+]([O-])=O)=C2)=O)=O
  • Chemical Name
    7-(1H-Imidazol-1-yl)-6-nitro-2,3-dioxo-3,4-dihydro-1(2H)-quinoxalineacetic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Shimizu-Sasamata M, et al. Stroke. 1998 Oct;29(10):2141-8. 2. Takahashi M, et al. J Pharmacol Exp Ther. 1998 Feb;284(2):467-73. 3. Kohara A, et al. J Pharm Pharmacol. 1998 Jul;50(7):795-801.
molnova catalog
related products
  • Tezampanel

    Tezampanel (LY 293558, NGX 424) is a competitive antagonist of the AMPA and kainate receptors with selectivity for the GluR5 subtype of the kainate receptor.

  • Rislenemdaz mesylate

    Rislenemdaz (MK 0657;CERC 301) is a potent, orally bioavailable, brain‐penetrant, NR2B-selective NMDA receptor (GluN2B) antagonist with Ki and IC 50 of 8.1 nM and 3.6 nM respectively.

  • Dynorphin A 1-10

    Dynorphin A (1-10), an endogenous opioid neuropeptide, binds to extracellular loop 2 of the κ-opioid receptor. Dynorphin A (1-10) also blocks NMDA-activated current with an IC50 of 42.0 μM.